25 results on '"Mathiasen, Anders B."'
Search Results
2. Clinical Gene and Stem Cell Therapy in Patients with Acute and Chronic Myocardial Ischemia
3. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease: A preliminary study
4. Angiographic Features and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Patients With First-Time Acute Coronary Syndrome
5. Value of cardiac 320-multidetector computed tomography and cardiac magnetic resonance imaging for assessment of myocardial perfusion defects in patients with known chronic ischemic heart disease
6. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging
7. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study
8. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
9. Bone marrow‐derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4‐year follow‐up of the MSC‐HF trial
10. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: Reproducibility and comparison of two T2-weighted protocols
11. Bone marrow-derived mesenchymal stromal cell treatment in patients with ischaemic heart failure: final 4-year follow-up of the MSC-HF trial.
12. Erratum to “Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat–derived platelet concentrates” [Cytotherapy 2017;19:222–234]
13. Ultrastructural characterization of mesenchymal stromal cells labeled with ultrasmall superparamagnetic iron-oxide nanoparticles for clinical tracking studies
14. Direct Intramyocardial Mesenchymal Stromal Cell Injections in Patients with Severe Refractory Angina: One-Year Follow-Up
15. Myocardial area at risk after ST-elevation myocardial infarction measured with the late gadolinium enhancement after scar remodeling and T2-weighted cardiac magnetic resonance imaging
16. Myocardial area at risk and salvage measured by T2-weighted cardiovascular magnetic resonance: Reproducibility and comparison of two T2-weighted protocols
17. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease
18. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina
19. MESENCHYMAL STEM CELLS THERAPY IN PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE: 12 MONTHS FOLLOW-UP
20. MYOCARDIUM AREA AT RISK MEASURED WITH DELAYED ENHANCEMENT AFTER SCAR REMODELING COMPARED WITH T2-WEIGHTED CARDIAC MAGNETIC RESONANCE IMAGING
21. Myocardium area at risk measured with delayed enhancement after scar remodelling compared with T2-weighted cardiac magnetic resonance imaging
22. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial.
23. PLASMA YKL-40 IN RELATION TO THE DEGREE OF CORONARY ARTERY DISEASE IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
24. Experimental myocardial stem cell therapy for ST-elevation myocardial infarction: rationale and level of evidence.
25. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.